Tumors induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy
about
Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and CancerState-of-the-art of regulatory dendritic cells in cancerTrial watch: Dendritic cell-based anticancer immunotherapy.Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells
P2860
Tumors induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Tumors induce immune tolerance ...... arget for cancer immunotherapy
@ast
Tumors induce immune tolerance ...... arget for cancer immunotherapy
@en
type
label
Tumors induce immune tolerance ...... arget for cancer immunotherapy
@ast
Tumors induce immune tolerance ...... arget for cancer immunotherapy
@en
prefLabel
Tumors induce immune tolerance ...... arget for cancer immunotherapy
@ast
Tumors induce immune tolerance ...... arget for cancer immunotherapy
@en
P2860
P1433
P1476
Tumors induce immune tolerance ...... arget for cancer immunotherapy
@en
P2093
Amol Suryawanshi
Santhakumar Manicassamy
P2860
P304
P356
10.1080/2162402X.2015.1052932
P577
2015-06-26T00:00:00Z